While these remarks largely summarize actions FDA has already taken, they highlight compounded GLP-1 products as an area of concern, and this area is likely to be one of continued FDA interest in 2026
Moreover, a favorable impact of GLP-1RAs on cardiac remodeling can occur through activation of the eNOS/cyclic guanosine monophosphate (cGMP)/protein kinase G (PKG) nexus [72]
The conventional thyroid conversion chart used by most doctors tends to be overly conservative, which often results in patients being underdosed when they switch medications
In most other cases, your dietitian must request your authorization to disclose any PHI, or you have the opportunity to object to disclosure
Patients are now going to ask, and you have every right to ask as far as I'm concerned
Clinical protocols typically increase doses every one to two weeks, with maximum weight loss occurring at higher maintenance doses of 1.0 to 2.4 milligrams weekly